Mostrando 6 resultados de: 6
Filtros aplicados
Subtipo de publicación
Article(6)
Publisher
Vaccine(2)
Veterinary Immunology and Immunopathology(2)
Clinical and Vaccine Immunology(1)
Journal of Biotechnology(1)
Classical swine fever virus E2 glycoprotein antigen produced in adenovirally transduced PK-15 cells confers complete protection in pigs upon viral challenge
ArticleAbstract: E2 is the major envelope glycoprotein present on the outer surface of the classical swine fever viruPalabras claves:Adenovirus, classical swine fever, E2 glycoprotein, Protein production system, Veterinary vaccineAutores:Borroto C., Castell S., Farnos O., Figueroa N., Frias M.T., Ganges L., Maritza Barrera, Montesino R., Naranjo P., Rodriguez M.P., Sanchez O., Toledo J.R., Venereo A.Fuentes:scopusEarly onset and long lasting protection in pigs provided by a classical swine fever E2-vaccine candidate produced in the milk of goats
ArticleAbstract: For vaccination against classical swine fever virus (CSFV), it is strongly desirable to induce a rapPalabras claves:CSFV, Duration of protection, E2 glycoprotein, Recombinant vaccinesAutores:Ávila M., Domínguez P., Farnos O., Frias M.T., Maritza Barrera, Rodriguez M.P., Sanchez O., Tait H., Toledo J.R., Vega E.Fuentes:scopusEffectiveness of the E2-classical swine fever virus recombinant vaccine produced and formulated within whey from genetically transformed goats
ArticleAbstract: Subunit recombinant vaccines against classical swine fever virus (CSFV) are a promising alternativePalabras claves:Autores:Cortez-San Martín M., Farnos O., Maritza Barrera, Meza C.D., Parra N.C., Rivas C.I., Saavedra P.A., Salgado E.R., Sanchez O., Toledo J.R.Fuentes:scopusHighly protective E2-CSFV vaccine candidate produced in the mammary gland of adenoviral transduced goats
ArticleAbstract: Classical swine fever virus is the etiological agent of the most economically important highly contaPalabras claves:Adenoviral transduction, CSFV, E2 glycoprotein, Goat milk, Mammary gland, Veterinary vaccineAutores:Alfonso P., Cremata J.A., Farnos O., Frias M.T., Ganges L., Maritza Barrera, Montesino R., Oramas N., Rodríguez E., Rodriguez M.P., Sanchez O., Santana E., Toledo J.R., Vega E.Fuentes:scopusHuman αIFN co-formulated with milk derived E2-CSFV protein induce early full protection in vaccinated pigs
ArticleAbstract: Subunit vaccines are a suitable alternative for the control of classical swine fever. However, suchPalabras claves:E2-CSFV, Emergency vaccine, Human interferon, Subunit vaccineAutores:Aguero F., Farnos O., Gómez S., Maritza Barrera, Ormazabal V., Parra N.C., Rodriguez M.P., Sanchez O., Suárez L., Toledo J.R.Fuentes:scopusThermal stress treatment does not affect the stability and protective capacity of goat milk derived E2-marker vaccine formulation against CSFV
ArticleAbstract: Classical swine fever virus produces a huge mortality in infected herds during recurrent outbreaks,Palabras claves:E2-classical swine fever virus, Formulation stability, Mammary gland expression, Recombinant veterinary vaccineAutores:Aguero F., Aguilera A., Castell S., Farnos O., Figueredo J.M., Fonseca-Rodríguez O., Frias M.T., Maritza Barrera, Montesino R., Naranjo P., Prieto Y., Rodriguez M.P., Sanchez O., Toledo J.R.Fuentes:scopus